Skip to content
Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Q3’25 Psychedelic Lobbying Update

Q3’25 Psychedelic Lobbying Update

  • Post published:October 29, 2025
  • Post category:Analysis/News/Pα+
Read more about the article The Psychedelic News Feed: October 20 – 26, 2025

The Psychedelic News Feed: October 20 – 26, 2025

  • Post published:October 27, 2025
  • Post category:Psychedelic News Feed Archive
Read more about the article Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

  • Post published:October 24, 2025
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article Q3’25 Investor Survey: What are Investors Most Concerned About?

Q3’25 Investor Survey: What are Investors Most Concerned About?

  • Post published:October 23, 2025
  • Post category:Analysis/News/Pα+
Read more about the article A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

  • Post published:October 22, 2025
  • Post category:Interviews
Read more about the article Q3’25 Survey: What are Psychedelics Investors Excited About?

Q3’25 Survey: What are Psychedelics Investors Excited About?

  • Post published:October 21, 2025
  • Post category:Analysis/News/Pα+
Read more about the article The Psychedelic News Feed: October 13 – 19, 2025

The Psychedelic News Feed: October 13 – 19, 2025

  • Post published:October 20, 2025
  • Post category:Psychedelic News Feed Archive
Read more about the article September 2025 Psychedelic Patent Update

September 2025 Psychedelic Patent Update

  • Post published:October 20, 2025
  • Post category:Psychedelic Patent Analysis/Pα+
Read more about the article Psychedelic Funding Update: Q3 2025

Psychedelic Funding Update: Q3 2025

  • Post published:October 16, 2025
  • Post category:Analysis/Pα+
Read more about the article Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

  • Post published:October 14, 2025
  • Post category:Interviews/Pα+

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More